Eye on emu for BioProspect

By Kate McDonald
Monday, 11 May, 2009

Brisbane’s BioProspect is hoping to enter the human natural health market by purchasing Melbourne dietary supplement company Re-Gen.

BioProspect is close to commercialisation with its lead product, a natural solution for termites called Termilone, and is also developing a range of plant extracts for animal health and nutrition called Bioeffectives.

The company said in a statement that Re-Gen’s product range was a natural fit with BioProspect’s other products.

Re-Gen has developed a range of products, including purified emu oil, as dietary supplements and as a therapy for skin, muscle and joint conditions. The company already has approval to market seven products in China, and will be concentrating on this market as well as Australia and overseas.

BioProspect is currently doing due diligence and will make a decision within 90 days.

Related News

AusBiotech partners with Tenmile

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

Australian CDC issues update in wake of Ebola outbreak

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...

Australia announces $7.2m diphtheria outbreak response package

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd